Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-07-25

Clinical Trial Update: Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of Irinotecan [NA]

View source ↗

Summary

A clinical trial update describing a study examining how genetic polymorphisms in drug transporters and orphan nuclear receptors influence irinotecan treatment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irinotecan (Irinotecan)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Colorectal Neoplasms, Secondary | NA | Status: UNKNOWN